Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy

Concurrent chemoradiation therapy (CRT) is the standard of care for patients with unresectable stage II/III lung cancer. However, systemic chemotherapy is required for patients who are ineligible for radical radiation therapy. There is little evidence to date for the safety and efficacy of CRT admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubara, Taichi, Takamori, Shinkichi, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Yamaguchi, Masafumi, Seto, Takashi, Okamoto, Tatsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636214/
https://www.ncbi.nlm.nih.gov/pubmed/34689423
http://dx.doi.org/10.1111/1759-7714.14200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636214/
https://www.ncbi.nlm.nih.gov/pubmed/34689423
http://dx.doi.org/10.1111/1759-7714.14200

Ejemplares similares